U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C21H24ClN3O3
Molecular Weight 401.887
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FOMINOBEN

SMILES

CN(CC(=O)N1CCOCC1)CC2=C(Cl)C=CC=C2NC(=O)C3=CC=CC=C3

InChI

InChIKey=KSNNEUZOAFRTDS-UHFFFAOYSA-N
InChI=1S/C21H24ClN3O3/c1-24(15-20(26)25-10-12-28-13-11-25)14-17-18(22)8-5-9-19(17)23-21(27)16-6-3-2-4-7-16/h2-9H,10-15H2,1H3,(H,23,27)

HIDE SMILES / InChI
Fominoben is a medication indicated for the treatment of dry cough. The drug was marketed under the name Noleptan, however, its current status is unknown and supposed to be "discontinued".

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
NOLEPTAN

Approved Use

Indicated for the treatment of irritative dry cough, especially during the night hours; to treat dry cough in smokers or in patients after surgery.
Doses

Doses

DosePopulationAdverse events​
160 mg 3 times / day multiple, oral
Dose: 160 mg, 3 times / day
Route: oral
Route: multiple
Dose: 160 mg, 3 times / day
Sources:
unhealthy
Health Status: unhealthy
Sex: M+F
Food Status: UNKNOWN
Sources:
PubMed

PubMed

TitleDatePubMed
[Evidence-based medicine in urology].
2007-10
Patents

Patents

Sample Use Guides

One pill 2-3 times a day.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Name Type Language
FOMINOBEN
INN   MI   WHO-DD  
INN  
Official Name English
PB 89 FREE BASE
Preferred Name English
3'-CHLORO-.ALPHA.-(METHYL((MORPHOLINOCARBONYL)METHYL)AMINO)-O-BENZOTOLUIDIDE
Common Name English
PB-89 FREE BASE
Code English
FOMINOBEN [MI]
Common Name English
fominoben [INN]
Common Name English
Fominoben [WHO-DD]
Common Name English
Code System Code Type Description
NCI_THESAURUS
C170002
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
ChEMBL
CHEMBL1697837
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
DRUG CENTRAL
1234
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
DRUG BANK
DB08968
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
EPA CompTox
DTXSID1023075
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
INN
3260
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
FDA UNII
TJ2KK6NYJS
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
ECHA (EC/EINECS)
241-964-4
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
SMS_ID
100000080411
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
MERCK INDEX
m5525
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY Merck Index
MESH
C073322
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
CAS
18053-31-1
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
EVMPD
SUB07777MIG
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
RXCUI
183875
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY RxNorm
WIKIPEDIA
Fominoben
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
PUBCHEM
3407
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY